An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects
Clinical trial NCT03446274 · UNKNOWN
Trial details
- NCT number
- NCT03446274
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-02
- Primary completion
- 2018-04-23
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.